Human urinary kallidinogenase in acute ischemic stroke: A single‐arm, multicenter, phase IV study (RESK study)

AIMS: Human urinary kallidinogenase (HUK) has shown favorable efficacies in acute ischemic stroke (AIS) treatment. We sought confirmation of the safety and efficacy of HUK for AIS in a large population. METHODS: RESK study enrolled patients with AIS of anterior circulation to receive HUK infusion. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Jun, Yao, Ming, Wang, Li‐Hua, Yu, Ming, Li, Run‐Hui, Zhao, Li‐Hong, Wang, Jia‐Chun, Wang, Yin‐Zhou, Wang, Xin, Song, Hai‐Qing, Luo, Ben‐Yan, Wang, Jia‐Wei, Huang, Yi‐Ning, Cui, Li‐Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611767/
https://www.ncbi.nlm.nih.gov/pubmed/34510762
http://dx.doi.org/10.1111/cns.13724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611767/
https://www.ncbi.nlm.nih.gov/pubmed/34510762
http://dx.doi.org/10.1111/cns.13724

Ejemplares similares